GSK926
GSK926 (compound 3) is a selective histone lysine methyltransferase EZH2 inhibitor (IC50=0.02 μM; Ki=7.9 nM), with SAM-competitive and cell-active properties. GSK926 can be used in cancer research[1].
Product Specifications
CAS Number
1346704-13-9
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gsk926.html
Smiles
O=C(C1=CC(C2=CC=C(N3CCN(CC3)C)N=C2)=CC4=C1C=NN4C(C)C)NCC5=C(C)C=C(C)NC5=O
Molecular Formula
C29H35N7O2
Molecular Weight
513.63
References & Citations
[1]Verma S K, et al. Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2[J]. ACS medicinal chemistry letters, 2012, 3 (12) : 1091-1096.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EZH2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KLR0343 96 Well
Rat basic Fibroblast Growth Factor 6, bFGF-6 GENLISA ELISA
Sign In for Pricing
View Details 
MBS2571246-03 5x 0.1 mg
Recombinant Rat CD146/MCAM protein (His tag)
Sign In for Pricing
View Details 